[HTML][HTML] Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO
X Kuang, Z Zhang, D Li, W Bao, J Pan, P Zhou… - Cellular & Molecular …, 2023 - Springer
Background Bladder cancer (BLCA) is a malignancy that frequently metastasizes and leads
to poor patient prognosis. It is essential to understand the molecular mechanisms underlying …
to poor patient prognosis. It is essential to understand the molecular mechanisms underlying …
Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer
Background The prostate‐specific phosphatase and tensin homolog deleted on
chromosome 10 (Pten) gene‐conditional knockout (KO) mouse carcinogenesis model is …
chromosome 10 (Pten) gene‐conditional knockout (KO) mouse carcinogenesis model is …
[PDF][PDF] Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer
MD Cheng Jiang - 2020 - researchgate.net
Background: The prostate‐specific phosphatase and tensin homolog deleted on
chromosome 10 (Pten) gene‐conditional knockout (KO) mouse carcinogenesis model is …
chromosome 10 (Pten) gene‐conditional knockout (KO) mouse carcinogenesis model is …
Prävalenz und klinische Signifikanz der 16q22-Deletion beim Mammakarzinom
MM Graser - 2021 - ediss.sub.uni-hamburg.de
Das Mammakarzinom ist der häufigste maligne Tumor bei Frauen. Die Therapie besteht
üblicherweise aus einer operativen Entfernung des Tumors mit anschließender Bestrahlung …
üblicherweise aus einer operativen Entfernung des Tumors mit anschließender Bestrahlung …
lncRNA F11-AS1 Suppressed Cervical Cancer Biological Activities by Vitro Study
C Xu, J Zhai, Y Fu - Journal of Biomaterials and Tissue …, 2019 - ingentaconnect.com
Objection: The purpose of this work was to discuss the effects and relative mechanisms of
F11-AS1 in cervical cancer treatment by vitro study. Methods: 20 pairs of cervical carcinoma …
F11-AS1 in cervical cancer treatment by vitro study. Methods: 20 pairs of cervical carcinoma …